ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis
MONDAY, Nov. 21, 2022 (HealthDay News) — Opioid initiation among patients with rheumatoid arthritis (RA) is associated with similar major adverse cardiovascular events (MACE) and all-cause mortality risk versus nonsteroidal anti-inflammatory drug (NS…
Learn MoreReduzca su presión arterial con mindfulness
MARTES, 8 de noviembre de 2022 (HealthDay News) — El mindfulness es una práctica de siglos de antigüedad que se ha puesto de moda en los últimos años, y un nuevo estudio afirma ahora que puede ayudar a su salud.Entrenarse en mindfulness puede ayudar …
Learn MoreTake the Mindful Way to Lower Blood Pressure
TUESDAY, Nov. 8, 2022 (HealthDay News) — Mindfulness is a centuries-old practice that’s become trendy in recent years — and a new study now says it can help your heart health.Training in mindfulness can help people better manage their high blood pre…
Learn MoreNew Drug Helps Tame Uncontrolled High Blood Pressure
TUESDAY, Nov. 8, 2022 (HealthDay News) – Some patients with high blood pressure can’t get it under control with standard medications, but a new study shows an experimental drug is up to the task of treating these tough-to-treat cases.Why do some folks…
Learn More¿Cómo afectó la pandemia a la presión arterial de los estadounidenses?
JUEVES, 3 de noviembre de 2022 (HealthDay News) — Aunque los niveles de presión arterial de los estadounidenses aumentaron durante la pandemia de COVID-19, una nueva investigación sugiere que podría haber sido mucho peor.”Previmos que el control de l…
Learn MoreAHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients
FRIDAY, Nov. 4, 2022 (HealthDay News) — Once-daily edoxaban seems safe and effective for pediatric patients with cardiac disease, according to a study presented at the American Heart Association Scientific Sessions 2022, held from Nov. 5 to 7 in Chic…
Learn MoreHow the Pandemic Affected Americans’ Blood Pressure
THURSDAY, Nov. 3, 2022 (HealthDay News) — Although blood pressure levels among Americans rose during the COVID-19 pandemic, new research suggests things could have been far worse.”We expected blood pressure control to be worse due to decreased physic…
Learn MoreMeta-Analysis Shows Decrease in Dementia Risk With HTN Treatment
WEDNESDAY, Nov. 2, 2022 (HealthDay News) — Antihypertensive treatment is associated with a reduced risk for dementia, according to an individual patient data meta-analysis from randomized clinical trials published online Oct. 25 in the European Heart…
Learn MoreGI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib
TUESDAY, Nov. 1, 2022 (HealthDay News) — For patients with atrial fibrillation (AF), apixaban use is associated with a lower risk for gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants (DOACs), according to a study publish…
Learn MoreBenefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
TUESDAY, Nov. 1, 2022 (HealthDay News) — Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspiri…
Learn More